Jia et al [41] investigated the expression levels of serum HIF-1α and VEGF pre- and post-TACE in patients with HCC, and correlations between prognosis factors and serum HIF-1α as well as VEGF levels. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.